TRIVAGIZOLE 3 Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Trivagizole 3, and what generic alternatives are available?
Trivagizole 3 is a drug marketed by Taro and is included in one NDA.
The generic ingredient in TRIVAGIZOLE 3 is clotrimazole. There are eleven drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the clotrimazole profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Trivagizole 3
A generic version of TRIVAGIZOLE 3 was approved as clotrimazole by P AND L on July 16th, 1993.
Summary for TRIVAGIZOLE 3
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 6 |
Raw Ingredient (Bulk) Api Vendors: | 126 |
Patent Applications: | 4,214 |
Formulation / Manufacturing: | see details |
DailyMed Link: | TRIVAGIZOLE 3 at DailyMed |
Pharmacology for TRIVAGIZOLE 3
Drug Class | Azole Antifungal |
Anatomical Therapeutic Chemical (ATC) Classes for TRIVAGIZOLE 3
US Patents and Regulatory Information for TRIVAGIZOLE 3
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Taro | TRIVAGIZOLE 3 | clotrimazole | CREAM;VAGINAL | 021143-001 | Apr 12, 2000 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |